The High Court has upheld a decision that found Helensburgh Coal should have tried to redeploy 22 workers it dismissed as redundant and replaced with contractors.
Mayne Pharma has denied US drug maker Cosette’s claims it breached its continuous disclosure obligations in relation to US FDA concerns about marketing for its Nextstellis contraceptive, as the drug makers spar over their $672 million merger.
Genomic sequencing company Oxford Nanopore Technologies has sued MGI Australia alleging infringement of four patents covering nanopore technology.
A Sydney barrister who won defamation proceedings against Nine over an Instagram-famous cavoodle has sought to disqualify a judge from hearing a dispute with her solicitors over costs, citing a lunch he had with Nine’s silk.
Construction company Lipman has struck out in its bid to claw back a $7 million payment determination made in A-Civil’s favour, with a court finding no error by an adjudicator.
The applicant in a long-running class action over the government’s live exports ban has lodged an appeal after a judge has found that no additional cattle would have been exported to Indonesia in 2012 and 2013 if the ban had not been in place.
Construction giant Lendlease has retained its rights to the ‘Civil & Civic’ name despite the brand falling into disuse, with IP Australia accepting the company retained a reputation in the valuable legacy trade mark.
Craft brewer Better Beer has lost a challenge to rival TRADIE’s bid to register a trade mark for the promotional phrase ‘TRADIE Beer Built Better’, with IP Australia finding no real danger of confusion between the brands.
A class action against aged care provider Bupa faced tough questions by a judge on Monday, who grilled counsel over the case’s theory of loss. And the answers — rather than reassuring her — raised the spectre of a summary judgment fight.
A court has heard US drug maker Cosette may amend its case to accuse Adelaide’s Mayne Pharma of continuous disclosure breaches in their battle over the termination of their $672 million merger.